U.S. Research Antibodies Market Size, Share & Trends Analysis Report By Product, By Specificity (Monoclonal, Polyclonal), By Technology, By Source, By Application, By End-use, And Segment Forecasts, 2024 - 2030

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                    1.2. Segment Definitions
                        1.2.1. Product
                        1.2.2. Specificity
                        1.2.3. Technology
                        1.2.4. Source
                        1.2.5. Application
                        1.2.6. End-use
                        1.2.7. Estimates and forecasts timeline
                    1.3. Research Methodology
                    1.4. Information Procurement
                        1.4.1. Purchased database
                        1.4.2. GVR’s internal database
                        1.4.3. Secondary sources
                        1.4.4. Primary research
                        1.4.5. Details of primary research
                    1.5. Information or Data Analysis
                        1.5.1. Data analysis models
                    1.6. Market Formulation & Validation
                    1.7. Model Details
                        1.7.1. Commodity flow analysis (Model 1)
                        1.7.2. Approach 1: Commodity flow approach
                        1.7.3. Volume price analysis (Model 2)
                        1.7.4. Approach 2: Volume price analysis
                    1.8. List of Secondary Sources
                    1.9. List of Primary Sources
                    1.10. Objectives
Chapter 2. Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Outlook
                        2.2.1. Product Outlook
                        2.2.2. Specificity Outlook
                        2.2.3. Technology Outlook
                        2.2.4. Source Outlook
                        2.2.5. Application Outlook
                        2.2.6. End-use Outlook
                    2.3. Competitive Insights
Chapter 3. U.S. Research Antibodies Market Variables, Trends & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent market outlook
                        3.1.2. Related/ancillary market outlook
                    3.2. Market Dynamics
                        3.2.1. Market driver analysis
                        3.2.2. Market restraint analysis
                        3.2.3. Market opportunity analysis
                            3.3. U.S. Research Antibodies Market Analysis Tools
                        3.3.1. Industry Analysis - Porter’s
                            3.3.1.1. Supplier power
                            3.3.1.2. Buyer power
                            3.3.1.3. Substitution threat
                            3.3.1.4. Threat of new entrant
                            3.3.1.5. Competitive rivalry
                        3.3.2. PESTEL Analysis
                            3.3.2.1. Political landscape
                            3.3.2.2. Technological landscape
                            3.3.2.3. Economic landscape
Chapter 4. U.S. Research Antibodies Market: Product Estimates & Trend Analysis
                    4.1. U.S. Research Antibodies Market: Product Dashboard
                    4.2. U.S. Research Antibodies Market: Product Movement Analysis
                    4.3. U.S. Research Antibodies Market Size & Forecasts and Trend Analyses, 2018 to 2030
                    4.4. Primary
                        4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                    4.5. Secondary
                        4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. U.S. Research Antibodies Market: Specificity Estimates & Trend Analysis
                    5.1. U.S. Research Antibodies Market: Specificity Dashboard
                    5.2. U.S. Research Antibodies Market: Specificity Movement Analysis
                    5.3. U.S. Research Antibodies Market Size & Forecasts and Trend Analyses, 2018 to 2030
                    5.4. Monoclonal Antibodies
                        5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                    5.5. Polyclonal Antibodies
                        5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. U.S. Research Antibodies Market: Technology Estimates & Trend Analysis
                    6.1. U.S. Research Antibodies Market: Technology Dashboard
                    6.2. U.S. Research Antibodies Market: Technology Movement Analysis
                    6.3. U.S. Research Antibodies Market Size & Forecasts and Trend Analyses, 2018 to 2030
                    6.4. Immunohistochemistry
                        6.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                    6.5. Immunofluorescence
                        6.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                    6.6. Western Blotting
                        6.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                    6.7. Flow Cytometry
                        6.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                    6.8. Immunoprecipitation
                        6.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                    6.9. ELISA
                        6.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                    6.10. Other Technologies
                        6.10.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. U.S. Research Antibodies Market: Source Estimates & Trend Analysis
                    7.1. U.S. Research Antibodies Market: Source Dashboard
                    7.2. U.S. Research Antibodies Market: Source Movement Analysis
                    7.3. U.S. Research Antibodies Market Size & Forecasts and Trend Analyses, 2018 to 2030
                    7.4. Mice
                        7.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                    7.5. Rabbit
                        7.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                    7.6. Goat
                        7.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                    7.7. Other Sources
                        7.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 8. U.S. Research Antibodies Market: Application Estimates & Trend Analysis
                    8.1. U.S. Research Antibodies Market: Application Dashboard
                    8.2. U.S. Research Antibodies Market: Application Movement Analysis
                    8.3. U.S. Research Antibodies Market Size & Forecasts and Trend Analyses, 2018 to 2030
                    8.4. Infectious Diseases
                        8.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                    8.5. Immunology
                        8.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                    8.6. Oncology
                        8.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                    8.7. Stem Cells
                        8.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                    8.8. Neurobiology
                        8.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                    8.9. Other Applications
                        8.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 9. U.S. Research Antibodies Market: End-use Estimates & Trend Analysis
                    9.1. U.S. Research Antibodies Market: End-use Dashboard
                    9.2. U.S. Research Antibodies Market: End-use Movement Analysis
                    9.3. U.S. Research Antibodies Market Size & Forecasts and Trend Analyses, 2018 to 2030
                    9.4. Academic & Research Institutes
                        9.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                    9.5. Contract Research Organizations
                        9.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                    9.6. Pharma & Biotech Companies
                        9.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 10. Competitive Landscape
                    10.1. Recent Developments & Impact Analysis, By Key Market Participants
                    10.2. Company/Competition Categorization
                    10.3. Vendor Landscape
                        10.3.1. List of key distributors and channel partners
                        10.3.2. Key customers
                        10.3.3. Key company market share analysis, 2023
                        10.3.4. Abcam Plc.
                            10.3.4.1. Company overview
                            10.3.4.2. Financial performance
                            10.3.4.3. Product benchmarking
                            10.3.4.4. Strategic initiatives
                        10.3.5. Merck KGaA
                            10.3.5.1. Company overview
                            10.3.5.2. Financial performance
                            10.3.5.3. Product benchmarking
                            10.3.5.4. Strategic initiatives
                        10.3.6. Thermo Fisher Scientific, Inc.
                            10.3.6.1. Company overview
                            10.3.6.2. Financial performance
                            10.3.6.3. Product benchmarking
                            10.3.6.4. Strategic initiatives
                        10.3.7. Cell Signalling Technology, Inc.
                            10.3.7.1. Company overview
                            10.3.7.2. Financial performance
                            10.3.7.3. Product benchmarking
                            10.3.7.4. Strategic initiatives
                        10.3.8. Santa Cruz Biotechnology Inc.
                            10.3.8.1. Company overview
                            10.3.8.2. Financial performance
                            10.3.8.3. Product benchmarking
                            10.3.8.4. Strategic initiatives
                        10.3.9. PerkinElmer, Inc.
                            10.3.9.1. Company overview
                            10.3.9.2. Financial performance
                            10.3.9.3. Product benchmarking
                            10.3.9.4. Strategic initiatives
                        10.3.10. Becton, Dickinson and Company
                            10.3.10.1. Company overview
                            10.3.10.2. Financial performance
                            10.3.10.3. Product benchmarking
                            10.3.10.4. Strategic initiatives
                        10.3.11. Bio-Techne Corporation
                            10.3.11.1. Company overview
                            10.3.11.2. Financial performance
                            10.3.11.3. Product benchmarking
                            10.3.11.4. Strategic initiatives
                        10.3.12. Proteintech Group, Inc.
                            10.3.12.1. Company overview
                            10.3.12.2. Financial performance
                            10.3.12.3. Product benchmarking
                            10.3.12.4. Strategic initiatives
                        10.3.13. Jackson ImmunoResearch Inc.
                            10.3.13.1. Company overview
                            10.3.13.2. Financial performance
                            10.3.13.3. Product benchmarking
                            10.3.13.4. Strategic initiatives

List of Tables

Table 1 List of abbreviation
Table 2 U.S. research antibodies market, 2018 - 2030 (USD Million)
Table 3 U.S. research antibodies market, by product, 2018 - 2030 (USD Million)
Table 4 U.S. research antibodies market, by specificity, 2018 - 2030 (USD Million)
Table 5 U.S. research antibodies market, by technology, 2018 - 2030 (USD Million)
Table 6 U.S. research antibodies market, by source, 2018 - 2030 (USD Million)
Table 7 U.S. research antibodies market, by application, 2018 - 2030 (USD Million)
Table 8 U.S. research antibodies market, by end-use, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 U.S. research antibodies market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Value chain based sizing & forecasting
Fig. 6 QFD modelling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Market snapshot
Fig. 9 Competitive landscape snapshot
Fig. 10 Product and stage segment snapshot
Fig. 11 Sales channel segment snapshot
Fig. 12 Market dynamics
Fig. 13 Porter’s five forces analysis
Fig. 14 PESTLE analysis
Fig. 15 U.S. research antibodies market: Product outlook and key takeaways
Fig. 16 U.S. research antibodies market: Product movement analysis
Fig. 17 Primary market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 18 Secondary market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 19 U.S. research antibodies market: Specificity outlook and key takeaways
Fig. 20 U.S. research antibodies market: Specificity movement analysis
Fig. 21 Monoclonal antibodies market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 Polyclonal antibodies market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 U.S. research antibodies market: Technology outlook and key takeaways
Fig. 24 U.S. research antibodies market: Technology movement analysis
Fig. 25 Immunohistochemistry market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 Immunofluorescence market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 Western blotting market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 Flow cytometry market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 29 Immunoprecipitation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 ELISA market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 Other technologies market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 U.S. research antibodies market: Source outlook and key takeaways
Fig. 33 U.S. research antibodies market: Source movement analysis
Fig. 34 Mice market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 35 Rabbit market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 36 Goat market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 37 Other sources market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 38 U.S. research antibodies market: Application outlook and key takeaways
Fig. 39 U.S. research antibodies market: Application movement analysis
Fig. 40 Infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 41 Immunology market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 42 Oncology market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 43 Stem cells market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 44 Neurobiology market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 45 Other applications market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 46 U.S. research antibodies market: End-use outlook and key takeaways
Fig. 47 U.S. research antibodies market: End-use movement analysis
Fig. 48 Academic & research institutes market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 49 Contract research organizations market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 50 Pharma & biotech companies market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 51 Company market share analysis, 2023
Fig. 52 Strategic framework